Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study In Healthy Subjects To Evaluate The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274

This study has been completed.
Information provided by:
Pfizer Identifier:
First received: August 25, 2010
Last updated: January 11, 2011
Last verified: January 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2011
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)